ポリメリック膜ベースのシステムは,皮膚経由の薬物投与に用いられる.
Laura Donato1, Paola Bernardo1
1Institute on Membrane Technology "Enrico Drioli" (National Research Council of Italy), 87036 Rende, Italy.
Polymers
|February 13, 2026
まとめ
コントローラド・ドラッグ・デリバリー・システム (CDDS) は,精密な治療法を提供する. TDDSは非侵襲的な経路を提供し,先進的な膜技術により患者の服従を高め,副作用を軽減します.
科学分野:
- ポリマー化学のポリマー化学について
- マテリアルサイエンス 材料科学
- メンブレーン技術 メンブレーン技術
- 医薬品科学 医薬品科学とは
背景:
- コントロールドラッグ・デリバリーシステム (CDDS) は,精密でカスタマイズされた疾患治療に不可欠です.
- 経皮薬剤投与システム (TDDS) は,胃の問題やファーストパス代謝を回避して,経口投与の非侵襲的な代替手段を提供します.
- 効果的なTDDSの開発には,ポリマー化学,材料科学,医薬品科学を統合した多学科的なアプローチが必要です.
研究 の 目的:
- コントロールされた薬物投与システムの包括的な概要を提供する.
- 膜工学の観点から,皮膚経由薬剤投与システム (TDDS) に焦点を当てること.
- ポリマー膜ベースのTDDSの材料と戦略について議論する.
主な方法:
- コントロールされたおよび皮膚経由の薬物投与システムに関する既存の文献のレビュー.
- パッシブおよびアクティブの皮膚経由投与戦略の分析.
- パッチ,混合マトリックス膜,インプリント膜を含む,様々な皮膚経膜ベースの放出システムの議論.
主要な成果:
- TDDSは,非侵襲的な薬物投与のために皮膚を利用し,患者の服従を改善し,全身的な副作用を回避します.
- ポリマー膜はTDDS製剤の重要な構成要素であり,ポリマー化学と材料科学の専門知識が必要です.
- パッシブとアクティブの両方の戦略は,様々な膜ベースのシステムとともに,効果的な皮膚経由の薬物投与のために使用されます.
結論:
- トランスダーマル・ドラッグ・デリバリー・システム (TDDS) は,制御された薬物投与における重要な進歩であり,治療効果を向上させています.
- 膜工学は,TDDSの設計と最適化において重要な役割を果たします.
- 様々な科学分野を統合することは,TDDS技術の継続的な革新と応用に不可欠です.
関連する概念動画
01:18Transdermal Drug Delivery Systems
4
Transdermal drug delivery systems (TDDS) enable the controlled release of drugs across the skin into systemic circulation. They are particularly advantageous for drugs with short half-lives or narrow therapeutic indices, as they maintain consistent plasma concentrations and reduce the risk of subtherapeutic or toxic levels.TDDS are categorized into monolithic, reservoir, and mixed systems. Monolithic systems embed the drug in a polymer matrix, where diffusion governs release. Reservoir systems...
4
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
2
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
2
01:23Ophthalmic Drug Delivery Systems
4
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
4
01:21Intrauterine Drug Delivery Systems
3
Controlled-release systems for intravaginal and intrauterine drug delivery have been developed primarily for the administration of contraceptive steroid hormones. These delivery routes circumvent first-pass hepatic metabolism, thereby enhancing bioavailability and allowing for reduced systemic dosages compared to oral administration. Such approaches contribute to improved therapeutic efficacy and patient compliance, particularly in long-term contraceptive regimens.Intravaginal Drug Delivery...
3
01:27Drug Delivery Systems: Different Types
2
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
2
01:26Oral Drug Delivery Systems: Continuous-Release Systems
2
Continuous-release drug delivery systems offer a strategic approach to maintaining therapeutic drug levels over extended periods following oral administration. By modulating the release rate of active pharmaceutical ingredients, these systems minimize fluctuations in plasma concentrations, which enhances clinical efficacy and reduces the need for frequent dosing. Such characteristics make them particularly advantageous in managing chronic diseases where patient adherence and stable drug...
2